Literature DB >> 18395901

Pancreatic stellate cells promote proliferation and invasiveness of human pancreatic cancer cells via galectin-3.

Hai-Biao Jiang1, Ming Xu, Xing-Peng Wang.   

Abstract

AIM: To investigate the role of pancreatic stellate cells (PSCs) and galectin-3 (GAL-3) in the proliferation and infiltration of pancreatic cancer cell line SW1990.
METHODS: Human pancreatic cancer cell line SW1990 and PSCs were cultured in vitro. Supernatant fluid of cultured PSCs and SW1990 cells was collected. Expression of GAL-3 in SW1990 cells and PSCs was detected by ELISA, RT-PCR and Western blotting. Proliferation of cultured PSCs and SW1990 cells was measured by 3-(4, 5-methylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay and flow cytometry. Infiltration of SW1990 cells was detected by a cell infiltration kit.
RESULTS: SW1990 cells expressed GAL-3 and this was up-regulated by the supernatant fluid of cultured PSCs. PSCs did not express GAL-3. SW1990 cells stimulated proliferation of PSCs via GAL-3. GAL-3 antibody inhibited SW1990 cell proliferation, while the supernatant fluid of PSCs stimulated proliferation of SW1990 cells through interaction with GAL-3 protein. The supernatant fluid of PSCs enhanced the invasiveness of SW1990 cells through interaction with GAL-3.
CONCLUSION: GAL-3 and PSCs were involved in the proliferation and infiltration process of pancreatic cancer cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18395901      PMCID: PMC2701522          DOI: 10.3748/wjg.14.2023

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  20 in total

1.  Upregulation of galectins-1 and -3 in human colon cancer and their role in regulating cell migration.

Authors:  Axel Hittelet; Hugues Legendre; Nathalie Nagy; Yves Bronckart; Jean-Claude Pector; Isabelle Salmon; Paul Yeaton; Hans-Joachim Gabius; Robert Kiss; Isabelle Camby
Journal:  Int J Cancer       Date:  2003-01-20       Impact factor: 7.396

Review 2.  Galectins. Structure and function of a large family of animal lectins.

Authors:  S H Barondes; D N Cooper; M A Gitt; H Leffler
Journal:  J Biol Chem       Date:  1994-08-19       Impact factor: 5.157

3.  Increased expression of galectin-3 in primary gastric cancer and the metastatic lymph nodes.

Authors:  Junichi Miyazaki; Ryota Hokari; Shingo Kato; Yoshikazu Tsuzuki; Atushi Kawaguchi; Shigeaki Nagao; Kazuro Itoh; Soichiro Miura
Journal:  Oncol Rep       Date:  2002 Nov-Dec       Impact factor: 3.906

4.  Transforming growth factor-beta1 induces desmoplasia in an experimental model of human pancreatic carcinoma.

Authors:  M Löhr; C Schmidt; J Ringel; M Kluth; P Müller; H Nizze; R Jesnowski
Journal:  Cancer Res       Date:  2001-01-15       Impact factor: 12.701

5.  Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells.

Authors:  Max G Bachem; Marion Schünemann; Marco Ramadani; Marco Siech; Hans Beger; Andreas Buck; Shaoxia Zhou; Alexandra Schmid-Kotsas; Guido Adler
Journal:  Gastroenterology       Date:  2005-04       Impact factor: 22.682

6.  Galectin-3 protects human breast carcinoma cells against nitric oxide-induced apoptosis: implication of galectin-3 function during metastasis.

Authors:  B K Moon; Y J Lee; P Battle; J M Jessup; A Raz; H R Kim
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

7.  Role of galaptin in ovarian carcinoma adhesion to extracellular matrix in vitro.

Authors:  H J Allen; D Sucato; B Woynarowska; S Gottstine; A Sharma; R J Bernacki
Journal:  J Cell Biochem       Date:  1990-05       Impact factor: 4.429

8.  Localization of galectin-3 in normal and diseased pancreatic tissue.

Authors:  C Schaffert; P M Pour; W G Chaney
Journal:  Int J Pancreatol       Date:  1998-02

9.  Extracellular matrix proteins protect pancreatic cancer cells from death via mitochondrial and nonmitochondrial pathways.

Authors:  Eva C Vaquero; Mouad Edderkaoui; Kyung J Nam; Ilya Gukovsky; Stephen J Pandol; Anna S Gukovskaya
Journal:  Gastroenterology       Date:  2003-10       Impact factor: 22.682

10.  Tumor-stroma interaction of human pancreatic cancer: acquired resistance to anticancer drugs and proliferation regulation is dependent on extracellular matrix proteins.

Authors:  Hidenori Miyamoto; Tatsuya Murakami; Kunihiro Tsuchida; Hiromu Sugino; Hidenori Miyake; Seiki Tashiro
Journal:  Pancreas       Date:  2004-01       Impact factor: 3.327

View more
  10 in total

1.  In vitro models of pancreatic cancer for translational oncology research.

Authors:  Georg Feldmann; Sherri Rauenzahn; Anirban Maitra
Journal:  Expert Opin Drug Discov       Date:  2009-04-01       Impact factor: 6.098

2.  Transient gene silencing of galectin-3 suppresses pancreatic cancer cell migration and invasion through degradation of β-catenin.

Authors:  Tsutomu Kobayashi; Tatsuo Shimura; Toshiki Yajima; Norio Kubo; Kenichiro Araki; Soichi Tsutsumi; Hideki Suzuki; Hiroyuki Kuwano; Avraham Raz
Journal:  Int J Cancer       Date:  2011-03-29       Impact factor: 7.396

3.  Transient silencing of galectin-3 expression promotes both in vitro and in vivo drug-induced apoptosis of human pancreatic carcinoma cells.

Authors:  Tsutomu Kobayashi; Tatsuo Shimura; Toshiki Yajima; Norio Kubo; Kenichiro Araki; Wataru Wada; Soichi Tsutsumi; Hideki Suzuki; Hiroyuki Kuwano; Avraham Raz
Journal:  Clin Exp Metastasis       Date:  2011-02-18       Impact factor: 5.150

4.  Pancreatic Tumor Microenvironment.

Authors:  Kai Wang; Hong He
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 5.  The emerging role of galectins in high-fatality cancers.

Authors:  Cherylane Dubé-Delarosbil; Yves St-Pierre
Journal:  Cell Mol Life Sci       Date:  2017-11-08       Impact factor: 9.261

6.  Inhibitors of Advanced Glycation End Product (AGE) Formation and Accumulation.

Authors:  Karly C Sourris; Anna Watson; Karin Jandeleit-Dahm
Journal:  Handb Exp Pharmacol       Date:  2021

7.  Comprehensive analysis of cellular galectin-3 reveals no consistent oncogenic function in pancreatic cancer cells.

Authors:  Alexander Hann; Anja Gruner; Ying Chen; Thomas M Gress; Malte Buchholz
Journal:  PLoS One       Date:  2011-06-16       Impact factor: 3.240

Review 8.  Pancreatic stellate cell: Pandora's box for pancreatic disease biology.

Authors:  Ratnakar R Bynigeri; Aparna Jakkampudi; Ramaiah Jangala; Chivukula Subramanyam; Mitnala Sasikala; G Venkat Rao; D Nageshwar Reddy; Rupjyoti Talukdar
Journal:  World J Gastroenterol       Date:  2017-01-21       Impact factor: 5.742

Review 9.  The Galectin Family as Molecular Targets: Hopes for Defeating Pancreatic Cancer.

Authors:  Noemí Manero-Rupérez; Neus Martínez-Bosch; Luis E Barranco; Laura Visa; Pilar Navarro
Journal:  Cells       Date:  2020-03-11       Impact factor: 6.600

10.  Galectin-3 gene silencing inhibits migration and invasion of human tongue cancer cells in vitro via downregulating β-catenin.

Authors:  Dong Zhang; Zheng-gang Chen; Shao-hua Liu; Zuo-qing Dong; Martin Dalin; Shi-san Bao; Ying-wei Hu; Feng-cai Wei
Journal:  Acta Pharmacol Sin       Date:  2012-10-29       Impact factor: 7.169

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.